Search company, investor...
Ever Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed | Alive

Total Raised


Last Raised

$1.11M | 3 yrs ago

About Ever Health

Ever Health is a Spanish company specialized in tele-medicine services. The company provides services through its two products: Kidscare, created to offer children and schools the possibility of having a medical service during all school hours, and People Care, designed to offer to companies, collectives, etc. the possibility of having a complete medical service in the office and solving day-to-day health problems.

Ever Health Headquarters Location

C / Juan Hurtado de Mendoza, 7. 1st Floor

Madrid, 28036,


(+34) 918 220 518

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ever Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ever Health is included in 2 Expert Collections, including Digital Health.


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,853 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest Ever Health News

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Mar 8, 2022

March 08, 2022 06:01 AM Eastern Standard Time Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme. Eurofins Genomics will be genotyping five million consenting participants within Our Future Health. This will provide important data that, when combined with other questionnaire and health information, will generate a comprehensive picture of population health in the UK, insights from which will be used to transform the prevention, detection and treatment of diseases. Our Future Health is the UK’s largest health research programme ever conducted, bringing together the public, charity and private sectors to research disease at an unprecedented scale in the UK. As one of Europe’s leading providers of genomics services, Eurofins Genomics will conduct the genotyping for the Our Future Health programme. To deliver this service, Eurofins Genomics will establish a dedicated laboratory in the UK, where it will carry out genotyping to identify genetic variations and combinations. Genetic variations such as changes of single building blocks of the DNA are associated with many known diseases. Eurofins Genomics will utilise specifically designed microarray technology with high accuracy and reproducibility to identify hundreds of thousands of genetic variations at a time. The resulting data will then be used to determine disease risks and discover biomarkers for diseases diagnosis and therapeutics. The goal of the Our Future Health programme is to facilitate the discovery and development of new methods of prevention, early detection and treatment of a wide range of diseases. Today, 59% of UK citizens aged 65 years or older have two or more serious health conditions, and this statistic has been projected to reach 70% by 2035. With the recruitment of five million adult volunteers, this research programme has the potential to improve the long-term health of millions of people in the UK and globally. The insights gained into links between DNA and diseases through this programme will accelerate the development of innovative solutions to help people to live healthier lives for longer. About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods. Eurofins Shares are listed on Euronext Paris Stock Exchange. Contacts

Ever Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ever Health Rank

  • When was Ever Health founded?

    Ever Health was founded in 2013.

  • Where is Ever Health's headquarters?

    Ever Health's headquarters is located at C / Juan Hurtado de Mendoza, 7., Madrid.

  • What is Ever Health's latest funding round?

    Ever Health's latest funding round is Seed.

  • How much did Ever Health raise?

    Ever Health raised a total of $1.62M.

  • Who are the investors of Ever Health?

    Investors of Ever Health include Toushka Capital, Medanest Medica and Santalucia Impulsa.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.